Image by Getty Images via DaylifeSteve Case‘s Revolution Health hasn’t quite lived up to the promise trumpeted in early days. Recent rounds of layoffs, changes in overall strategy, and the hiring of an investment bank to explore sales lead one to think that Revolution is closer to circling the drain that it is carrying the banner of a new approach to healthcare focused on the consumer.
However, one recent rumor about a merger between Glam and Revolution Health reminds us of the direction that health publishing (and potentially health care delivery) are likely to go if we believe that consumer decision-making is important.
As drug company ad budgets have buoyed Madison Ave and increasingly entered consumer lexicons, women are important health care decisionmakers and natural combinations between women’s interests and health decision-making could start to chip away at the insurance- and pharma/device- dominated M&A plays, to add further variety to the technology players already rattling sabers at the gates.
